To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Presence of hyaluronan in lung alveoli in severe Covid-19: an opening for new treatment options?
Public Health and Clinical Medicin, Umeå University, Umeå, Sweden.
Örebro University, School of Medical Sciences. Department of Laboratory Medicine.ORCID iD: 0000-0001-6881-237X
Umeå University, Umeå, Sweden.
Örebro University, School of Medical Sciences. Department of Infectious diseases.ORCID iD: 0000-0003-3921-4244
Show others and affiliations
2020 (English)In: Journal of Biological Chemistry, ISSN 0021-9258, E-ISSN 1083-351X, Vol. 295, no 45, p. 15418-15422Article in journal (Refereed) Published
Abstract [en]

Severe corona virus disease 2019 (Covid-19) is characterized by inflammation of the lungs with increasing respiratory impairment. In fatal Covid-19, lungs at autopsy have been filled with a clear liquid jelly. However, the nature of this finding has not yet been determined.The aim of the study was to demonstrate if the lungs of fatal Covid-19 contain hyaluronan as it is associated with inflammation and acute respiratory distress syndrome (ARDS) and may have the appearance of liquid jelly.Lung tissue obtained at autopsy from three deceased Covid-19 patients was processed for hyaluronan histochemistry using a direct staining method and compared with staining in normal lung tissue.Stainings confirmed that hyaluronan is obstructing alveoli with presence in exudate and plugs, as well as in thickened perialveolar interstitium. In contrast, normal lungs only showed hyaluronan in intact alveolar walls and perivascular tissue. This is the first study to confirm prominent hyaluronan exudates in the alveolar spaces of Covid-19 lungs, supporting the notion that the macromolecule is involved in ARDS caused by SARS-CoV-2. The present finding may open up for new treatment options in severe Covid-19, aiming at reducing the presence and production of hyaluronan in the lungs.

Place, publisher, year, edition, pages
American Society for Biochemistry and Molecular Biology, 2020. Vol. 295, no 45, p. 15418-15422
Keywords [en]
COVID-19, autopsy, coronavirus, extracellular matrix, glycosaminoglycan, hyaluronan, lung, virus
National Category
Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:oru:diva-86047DOI: 10.1074/jbc.AC120.015967ISI: 000591839400022PubMedID: 32978255Scopus ID: 2-s2.0-85095861098OAI: oai:DiVA.org:oru-86047DiVA, id: diva2:1471338
Funder
Swedish Heart Lung Foundation, 20200366Available from: 2020-09-28 Created: 2020-09-28 Last updated: 2024-01-10Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Karlsson, Mats G.Cajander, SaraDorofte, Luiza

Search in DiVA

By author/editor
Karlsson, Mats G.Cajander, SaraDorofte, Luiza
By organisation
School of Medical Sciences
In the same journal
Journal of Biological Chemistry
Respiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 205 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf